Pim-selective inhibitor DHPCC-9 reveals Pim kinases as potent stimulators of cancer cell migration and invasion




Santio NM, Vahakoski RL, Rainio EM, Sandholm JA, Virtanen SS, Prudhomme M, Anizon F, Moreau P, Koskinen PJ

PublisherBIOMED CENTRAL LTD

2010

Molecular Cancer

MOLECULAR CANCER

MOL CANCER

ARTN 279

9

13

1476-4598

DOIhttps://doi.org/10.1186/1476-4598-9-279

https://research.utu.fi/converis/portal/Publication/1643758



Conclusions: Altogether, our data indicate that DHPCC-9 is not only a powerful tool to investigate physiological effects of the oncogenic Pim family kinases, but also an attractive molecule for drug development to inhibit invasiveness of Pim-overexpressing cancer cells.

Last updated on 2024-26-11 at 16:15